Compare BLKB & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLKB | ATRC |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.8B |
| IPO Year | 2004 | 2005 |
| Metric | BLKB | ATRC |
|---|---|---|
| Price | $49.16 | $32.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $65.33 | $51.17 |
| AVG Volume (30 Days) | 503.1K | ★ 738.3K |
| Earning Date | 05-13-2026 | 05-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.32 | 74.74 |
| EPS | ★ 2.37 | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | $7.06 | $14.90 |
| Revenue Next Year | $3.48 | $12.87 |
| P/E Ratio | $21.00 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $45.71 | $28.32 |
| 52 Week High | $74.86 | $43.18 |
| Indicator | BLKB | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 35.85 |
| Support Level | $46.68 | $30.27 |
| Resistance Level | $50.32 | $33.69 |
| Average True Range (ATR) | 3.26 | 1.76 |
| MACD | 0.27 | -0.45 |
| Stochastic Oscillator | 34.67 | 28.94 |
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.